Literature DB >> 23867361

Kinetic characterization of arginine deiminase and carbamate kinase from Streptococcus pyogenes M49.

Silvio Hering1, Antje Sieg, Bernd Kreikemeyer, Tomas Fiedler.   

Abstract

Streptococcus pyogenes (group A Streptococcus, GAS) is an important human pathogen causing mild superficial infections of skin and mucous membranes, but also life-threatening systemic diseases. S. pyogenes and other prokaryotic organisms use the arginine deiminase system (ADS) for survival in acidic environments. In this study, the arginine deiminase (AD), and carbamate kinase (CK) from S. pyogenes M49 strain 591 were heterologously expressed in Escherichia coli DH5α, purified, and kinetically characterized. AD and CK from S. pyogenes M49 share high amino acid sequence similarity with the respective enzymes from Lactococcus lactis subsp. lactis IL1403 (45.6% and 53.5% identical amino acids) and Enterococcus faecalis V583 (66.8% and 66.8% identical amino acids). We found that the arginine deiminase of S. pyogenes is not allosterically regulated by the intermediates and products of the arginine degradation (e.g., ATP, citrulline, carbamoyl phosphate). The Km and Vmax values for arginine were 1.13±0.12mM (mean±SD) and 1.51±0.07μmol/min/mg protein. The carbamate kinase is inhibited by ATP but unaffected by arginine and citrulline. The Km and Vmax values for ADP were 0.72±0.08mM and 1.10±0.10μmol/min/mg protein and the Km for carbamoyl phosphate was 0.65±0.07mM. The optimum pH and temperature for both enzymes were 6.5 and 37°C, respectively.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arginine deiminase; Carbamate kinase; LAB; Lactic acid bacteria; Streptococcus pyogenes

Mesh:

Substances:

Year:  2013        PMID: 23867361     DOI: 10.1016/j.pep.2013.07.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  6 in total

1.  Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.

Authors:  Tomas Fiedler; Madlen Strauss; Silvio Hering; Ulrike Redanz; Doreen William; Yvonne Rosche; Carl Friedrich Classen; Bernd Kreikemeyer; Michael Linnebacher; Claudia Maletzki
Journal:  Cancer Biol Ther       Date:  2015-03-16       Impact factor: 4.742

2.  Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells.

Authors:  Christin Riess; Katharina Del Moral; Carl Friedrich Classen; Claudia Maletzki; Adina Fiebig; Philipp Kaps; Charlotte Linke; Burkhard Hinz; Anne Rupprecht; Marcus Frank; Tomas Fiedler; Dirk Koczan; Sascha Troschke-Meurer; Holger N Lode; Nadja Engel; Thomas Freitag
Journal:  Cell Death Dis       Date:  2022-06-18       Impact factor: 9.685

Review 3.  Acid Stress Response Mechanisms of Group B Streptococci.

Authors:  Sarah Shabayek; Barbara Spellerberg
Journal:  Front Cell Infect Microbiol       Date:  2017-09-07       Impact factor: 5.293

4.  The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated Streptococcus pyogenes Infections.

Authors:  Jeffrey A Freiberg; Yoann Le Breton; Janette M Harro; Devon L Allison; Kevin S McIver; Mark E Shirtliff
Journal:  mBio       Date:  2020-07-07       Impact factor: 7.867

5.  Enzymology of the pathway for ATP production by arginine breakdown.

Authors:  Tjeerd Pols; Shubham Singh; Cecile Deelman-Driessen; Bauke F Gaastra; Bert Poolman
Journal:  FEBS J       Date:  2020-05-05       Impact factor: 5.542

6.  PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes.

Authors:  Rico Schwarz; Eric Zitzow; Adina Fiebig; Silvio Hering; Yvonne Humboldt; Nina Schoenwaelder; Neele Kämpfer; Kerren Volkmar; Burkhard Hinz; Bernd Kreikemeyer; Claudia Maletzki; Tomas Fiedler
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-15       Impact factor: 4.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.